

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of monocyte differentiation (GO:0045655) | 6.03744334 |
| 2 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.97320500 |
| 3 | osteoclast differentiation (GO:0030316) | 5.82383019 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.55435590 |
| 5 | oligosaccharide catabolic process (GO:0009313) | 5.35452562 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 5.26098333 |
| 7 | regulation of activation of Janus kinase activity (GO:0010533) | 5.23154680 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.21011421 |
| 9 | response to peptidoglycan (GO:0032494) | 5.11759110 |
| 10 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.97589826 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 4.92562060 |
| 12 | positive regulation of type 2 immune response (GO:0002830) | 4.88389233 |
| 13 | glycosphingolipid catabolic process (GO:0046479) | 4.76737925 |
| 14 | positive regulation of osteoclast differentiation (GO:0045672) | 4.65277103 |
| 15 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.62612248 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.62316586 |
| 17 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.47895153 |
| 18 | regulation of vitamin metabolic process (GO:0030656) | 4.46188227 |
| 19 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.43520569 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.39955745 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.39955745 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.39955745 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.39955745 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.39955745 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.39955745 |
| 26 | positive regulation of macrophage differentiation (GO:0045651) | 4.37546996 |
| 27 | cellular response to exogenous dsRNA (GO:0071360) | 4.36953294 |
| 28 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.32017598 |
| 29 | glycolipid catabolic process (GO:0019377) | 4.29716928 |
| 30 | negative regulation of interleukin-17 production (GO:0032700) | 4.26346030 |
| 31 | granulocyte activation (GO:0036230) | 4.24064554 |
| 32 | positive regulation of bone resorption (GO:0045780) | 4.23985647 |
| 33 | positive regulation of bone remodeling (GO:0046852) | 4.23985647 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.22423898 |
| 35 | eosinophil chemotaxis (GO:0048245) | 4.22395650 |
| 36 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.17038934 |
| 37 | type I interferon signaling pathway (GO:0060337) | 4.16307114 |
| 38 | cellular response to type I interferon (GO:0071357) | 4.16307114 |
| 39 | negative regulation of viral genome replication (GO:0045071) | 4.12136209 |
| 40 | response to type I interferon (GO:0034340) | 4.11098354 |
| 41 | cellular response to interferon-beta (GO:0035458) | 4.09089146 |
| 42 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.05482424 |
| 43 | superoxide anion generation (GO:0042554) | 4.03505165 |
| 44 | T-helper 1 type immune response (GO:0042088) | 4.03353491 |
| 45 | positive regulation of interleukin-12 production (GO:0032735) | 4.02155721 |
| 46 | respiratory burst (GO:0045730) | 3.99193502 |
| 47 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.99123932 |
| 48 | positive regulation of T cell chemotaxis (GO:0010820) | 3.98073020 |
| 49 | regulation of T cell chemotaxis (GO:0010819) | 3.98073020 |
| 50 | cellular response to interferon-alpha (GO:0035457) | 3.96552445 |
| 51 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.95104949 |
| 52 | natural killer cell mediated immunity (GO:0002228) | 3.95104949 |
| 53 | regulation of immunoglobulin secretion (GO:0051023) | 3.93094167 |
| 54 | positive regulation of T cell cytokine production (GO:0002726) | 3.92046281 |
| 55 | reactive oxygen species biosynthetic process (GO:1903409) | 3.91411968 |
| 56 | ceramide catabolic process (GO:0046514) | 3.89515699 |
| 57 | neutrophil activation (GO:0042119) | 3.87206517 |
| 58 | regulation of T-helper cell differentiation (GO:0045622) | 3.86155395 |
| 59 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.85637529 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.85062421 |
| 61 | regulation of chemokine biosynthetic process (GO:0045073) | 3.84271854 |
| 62 | negative regulation of lipid storage (GO:0010888) | 3.83538724 |
| 63 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.82647963 |
| 64 | eosinophil migration (GO:0072677) | 3.77606312 |
| 65 | regulation of mononuclear cell migration (GO:0071675) | 3.77180214 |
| 66 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.77004796 |
| 67 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.76403179 |
| 68 | positive regulation of odontogenesis (GO:0042482) | 3.72895635 |
| 69 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.72464746 |
| 70 | positive regulation of interleukin-17 production (GO:0032740) | 3.72432538 |
| 71 | monocyte chemotaxis (GO:0002548) | 3.70853511 |
| 72 | regulation of interleukin-17 production (GO:0032660) | 3.68248351 |
| 73 | regulation of memory T cell differentiation (GO:0043380) | 3.66682946 |
| 74 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.63957257 |
| 75 | response to interferon-alpha (GO:0035455) | 3.63349480 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 3.62208293 |
| 77 | positive regulation of heat generation (GO:0031652) | 3.60602705 |
| 78 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.59682188 |
| 79 | regulation of fever generation (GO:0031620) | 3.58832986 |
| 80 | regulation of RIG-I signaling pathway (GO:0039535) | 3.58578506 |
| 81 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.57458006 |
| 82 | cellular response to zinc ion (GO:0071294) | 3.57308948 |
| 83 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.56837075 |
| 84 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.56007784 |
| 85 | immunoglobulin mediated immune response (GO:0016064) | 3.55443416 |
| 86 | regulation of T-helper 1 type immune response (GO:0002825) | 3.54867303 |
| 87 | defense response to protozoan (GO:0042832) | 3.51053206 |
| 88 | cellular response to virus (GO:0098586) | 3.48486560 |
| 89 | positive regulation of tissue remodeling (GO:0034105) | 3.48326285 |
| 90 | positive regulation of interferon-beta production (GO:0032728) | 3.48037706 |
| 91 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.47606414 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.46334325 |
| 93 | response to muramyl dipeptide (GO:0032495) | 3.43232312 |
| 94 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.43058029 |
| 95 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.42212453 |
| 96 | regulation of macrophage differentiation (GO:0045649) | 3.41014778 |
| 97 | regulation of cholesterol storage (GO:0010885) | 3.39093012 |
| 98 | positive regulation of myeloid leukocyte differentiation (GO:0002763) | 3.37164101 |
| 99 | macrophage activation involved in immune response (GO:0002281) | 3.35550223 |
| 100 | decidualization (GO:0046697) | 3.34780575 |
| 101 | negative regulation of interleukin-12 production (GO:0032695) | 3.33903007 |
| 102 | response to host immune response (GO:0052572) | 3.27195577 |
| 103 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.27195577 |
| 104 | regulation of heat generation (GO:0031650) | 3.26529433 |
| 105 | regulation of chronic inflammatory response (GO:0002676) | 3.26265582 |
| 106 | positive regulation of interleukin-10 production (GO:0032733) | 3.25213353 |
| 107 | positive regulation of lymphocyte migration (GO:2000403) | 3.24105332 |
| 108 | response to interferon-beta (GO:0035456) | 3.23773576 |
| 109 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.23502709 |
| 110 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.22072837 |
| 111 | positive regulation of interleukin-6 production (GO:0032755) | 3.21142863 |
| 112 | detection of molecule of bacterial origin (GO:0032490) | 3.19627446 |
| 113 | positive regulation of extracellular matrix organization (GO:1903055) | 3.19189710 |
| 114 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.17960510 |
| 115 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.16941939 |
| 116 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.16388001 |
| 117 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.16388001 |
| 118 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.15485113 |
| 119 | regulation of T cell cytokine production (GO:0002724) | 3.15192854 |
| 120 | regulation of interleukin-12 production (GO:0032655) | 3.14573395 |
| 121 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.14501897 |
| 122 | positive regulation of interleukin-2 production (GO:0032743) | 3.14423699 |
| 123 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.14079521 |
| 124 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.13167777 |
| 125 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.12554355 |
| 126 | cell adhesion mediated by integrin (GO:0033627) | 3.12199945 |
| 127 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11902365 |
| 128 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.11697645 |
| 129 | myeloid dendritic cell differentiation (GO:0043011) | 3.10992483 |
| 130 | response to lipoprotein particle (GO:0055094) | 3.09579583 |
| 131 | myeloid cell activation involved in immune response (GO:0002275) | 3.05940093 |
| 132 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02339845 |
| 133 | positive regulation of mast cell degranulation (GO:0043306) | 3.02339845 |
| 134 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.02199598 |
| 135 | regulation of podosome assembly (GO:0071801) | 3.01837403 |
| 136 | regulation of growth of symbiont in host (GO:0044126) | 3.01318298 |
| 137 | negative regulation of growth of symbiont in host (GO:0044130) | 3.01318298 |
| 138 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.01318298 |
| 139 | amino sugar catabolic process (GO:0046348) | 2.98113309 |
| 140 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.93332422 |
| 141 | dendritic cell differentiation (GO:0097028) | 2.92857617 |
| 142 | positive regulation of astrocyte differentiation (GO:0048711) | 2.91816585 |
| 143 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.91068096 |
| 144 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.90839567 |
| 145 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.90641508 |
| 146 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.89034125 |
| 147 | sphingolipid catabolic process (GO:0030149) | 2.86718006 |
| 148 | positive regulation of leukocyte degranulation (GO:0043302) | 2.85790039 |
| 149 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.84937865 |
| 150 | regulation of prostaglandin secretion (GO:0032306) | 2.84896661 |
| 151 | membrane lipid catabolic process (GO:0046466) | 2.84796165 |
| 152 | positive regulation of mast cell activation (GO:0033005) | 2.84656429 |
| 153 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.81222995 |
| 154 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.77313119 |
| 155 | wound healing, spreading of epidermal cells (GO:0035313) | 2.72017532 |
| 156 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.70251229 |
| 157 | germinal center formation (GO:0002467) | 2.68353532 |
| 158 | regulation of lymphocyte migration (GO:2000401) | 2.68176647 |
| 159 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.66686820 |
| 160 | positive regulation of prostaglandin secretion (GO:0032308) | 2.64181217 |
| 161 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.63922587 |
| 162 | tryptophan catabolic process (GO:0006569) | 2.58787801 |
| 163 | indole-containing compound catabolic process (GO:0042436) | 2.58787801 |
| 164 | indolalkylamine catabolic process (GO:0046218) | 2.58787801 |
| 165 | negative regulation of mast cell activation (GO:0033004) | 2.58439329 |
| 166 | regulation of interleukin-6 production (GO:0032675) | 2.57978327 |
| 167 | neutrophil chemotaxis (GO:0030593) | 2.56146528 |
| 168 | negative regulation of monooxygenase activity (GO:0032769) | 2.55496766 |
| 169 | positive regulation of calcium ion import (GO:0090280) | 2.54783180 |
| 170 | response to protozoan (GO:0001562) | 2.53864337 |
| 171 | myeloid leukocyte activation (GO:0002274) | 2.52532337 |
| 172 | peptide catabolic process (GO:0043171) | 2.52409674 |
| 173 | cellular response to lipopolysaccharide (GO:0071222) | 2.52085555 |
| 174 | granulocyte chemotaxis (GO:0071621) | 2.51961306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.29597553 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.73590012 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.51513606 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.23044657 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.89417664 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.15534339 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.81869212 |
| 8 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.57909571 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.52291040 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.48979388 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22683804 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.93216550 |
| 13 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70429953 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.61185944 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51286838 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.44627287 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37992319 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20229272 |
| 19 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.03810385 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.88579881 |
| 21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86468471 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70767658 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61765944 |
| 24 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59704933 |
| 25 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57724375 |
| 26 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48937687 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48238330 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45659963 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44506163 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.42678081 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.41567233 |
| 32 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41128839 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39803567 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38155104 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.34909649 |
| 36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34791033 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34791033 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33163171 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30990151 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30094256 |
| 41 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28767106 |
| 42 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28588764 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26104118 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25237888 |
| 45 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21830018 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21781102 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.20629969 |
| 48 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.19170997 |
| 49 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.19170997 |
| 50 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.19170997 |
| 51 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17704790 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14483419 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13821088 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13413613 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12462122 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12079071 |
| 57 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.05846116 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05668057 |
| 59 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04790877 |
| 60 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04621687 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04386988 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04232678 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01612862 |
| 64 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00856209 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99851856 |
| 66 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97750949 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96984210 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95232461 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93920504 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93730677 |
| 71 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.93614239 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.93203505 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93182012 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92842679 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92563413 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89711700 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89521728 |
| 78 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89411795 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88433239 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 0.88088732 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88057474 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86627966 |
| 83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.86275708 |
| 84 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.83658377 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83634088 |
| 86 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83144690 |
| 87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.81892434 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81884788 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81701529 |
| 90 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.81625630 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81614740 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.81571840 |
| 93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.79895774 |
| 94 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79894518 |
| 95 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.77949639 |
| 96 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76951122 |
| 97 | MAF_26560356_Chip-Seq_TH1_Human | 0.76816152 |
| 98 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.75692151 |
| 99 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75420667 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75321389 |
| 101 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.74845868 |
| 102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.74633706 |
| 103 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.74276049 |
| 104 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.74194167 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74138142 |
| 106 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.73487145 |
| 107 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72746346 |
| 108 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.72603394 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.72419210 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72389286 |
| 111 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.72042554 |
| 112 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70370442 |
| 113 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.69563448 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.68705523 |
| 115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68566974 |
| 116 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.67864241 |
| 117 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.67550674 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66380752 |
| 119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.65140864 |
| 120 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.64784884 |
| 121 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.64508631 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64416085 |
| 123 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64055806 |
| 124 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.62699716 |
| 125 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.62313086 |
| 126 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.61961335 |
| 127 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.61734754 |
| 128 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.60495854 |
| 129 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.60264931 |
| 130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.59128690 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58626182 |
| 132 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58599120 |
| 133 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.57658920 |
| 134 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.57225256 |
| 135 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.57225256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.13975077 |
| 2 | MP0009785_altered_susceptibility_to | 4.92771546 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 4.71792662 |
| 4 | MP0003436_decreased_susceptibility_to | 4.17339290 |
| 5 | MP0006082_CNS_inflammation | 4.14535461 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.72905893 |
| 7 | MP0003724_increased_susceptibility_to | 3.62761438 |
| 8 | * MP0005000_abnormal_immune_tolerance | 3.57075914 |
| 9 | MP0005025_abnormal_response_to | 3.42410095 |
| 10 | MP0002419_abnormal_innate_immunity | 3.35789244 |
| 11 | MP0005671_abnormal_response_to | 3.09622255 |
| 12 | MP0000685_abnormal_immune_system | 3.05852369 |
| 13 | MP0001790_abnormal_immune_system | 2.94059972 |
| 14 | MP0005387_immune_system_phenotype | 2.94059972 |
| 15 | MP0003303_peritoneal_inflammation | 2.82322035 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.72735512 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.72146255 |
| 18 | MP0009764_decreased_sensitivity_to | 2.66614372 |
| 19 | MP0002723_abnormal_immune_serum | 2.64892469 |
| 20 | MP0001727_abnormal_embryo_implantation | 2.45672705 |
| 21 | MP0004510_myositis | 2.37178923 |
| 22 | MP0001800_abnormal_humoral_immune | 2.37079211 |
| 23 | MP0001819_abnormal_immune_cell | 2.24766509 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.16787592 |
| 25 | MP0003329_amyloid_beta_deposits | 2.15157206 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.13091633 |
| 27 | MP0001853_heart_inflammation | 2.10773508 |
| 28 | MP0004947_skin_inflammation | 2.05546684 |
| 29 | MP0002006_tumorigenesis | 1.99362647 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.89420551 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.85050820 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.83277171 |
| 33 | MP0008469_abnormal_protein_level | 1.82275226 |
| 34 | MP0003448_altered_tumor_morphology | 1.79453287 |
| 35 | MP0003075_altered_response_to | 1.78825078 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.75983047 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.75873039 |
| 38 | MP0002405_respiratory_system_inflammati | 1.74996886 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.64622783 |
| 40 | MP0005310_abnormal_salivary_gland | 1.62050511 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.57075181 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.53861751 |
| 43 | MP0005647_abnormal_sex_gland | 1.53777400 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.53183006 |
| 45 | MP0004782_abnormal_surfactant_physiolog | 1.48361487 |
| 46 | * MP0000716_abnormal_immune_system | 1.48352211 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.40687838 |
| 48 | MP0003186_abnormal_redox_activity | 1.38111454 |
| 49 | MP0000858_altered_metastatic_potential | 1.36589351 |
| 50 | MP0005166_decreased_susceptibility_to | 1.34397508 |
| 51 | MP0000343_altered_response_to | 1.32699396 |
| 52 | MP0002398_abnormal_bone_marrow | 1.29496893 |
| 53 | MP0006054_spinal_hemorrhage | 1.27477834 |
| 54 | MP0003195_calcinosis | 1.26284164 |
| 55 | MP0004742_abnormal_vestibular_system | 1.22385990 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.22115249 |
| 57 | MP0005164_abnormal_response_to | 1.20844233 |
| 58 | MP0003690_abnormal_glial_cell | 1.16706825 |
| 59 | MP0009763_increased_sensitivity_to | 1.13273420 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.12709851 |
| 61 | MP0005257_abnormal_intraocular_pressure | 1.11847919 |
| 62 | MP0005410_abnormal_fertilization | 1.11467143 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.10541261 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.10541261 |
| 65 | MP0009278_abnormal_bone_marrow | 1.10518634 |
| 66 | * MP0002429_abnormal_blood_cell | 1.09395684 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.05690346 |
| 68 | MP0005390_skeleton_phenotype | 1.05684425 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.05149142 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.04156513 |
| 71 | MP0008260_abnormal_autophagy | 1.03466636 |
| 72 | MP0002332_abnormal_exercise_endurance | 1.03242813 |
| 73 | MP0003136_yellow_coat_color | 1.03010490 |
| 74 | MP0005365_abnormal_bile_salt | 1.02394397 |
| 75 | MP0003172_abnormal_lysosome_physiology | 0.89432214 |
| 76 | MP0005171_absent_coat_pigmentation | 0.89327180 |
| 77 | MP0000689_abnormal_spleen_morphology | 0.88640645 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 0.87600987 |
| 79 | MP0002722_abnormal_immune_system | 0.84321532 |
| 80 | MP0002163_abnormal_gland_morphology | 0.83834661 |
| 81 | MP0009840_abnormal_foam_cell | 0.83341202 |
| 82 | MP0003646_muscle_fatigue | 0.81631918 |
| 83 | MP0001542_abnormal_bone_strength | 0.80384218 |
| 84 | MP0002933_joint_inflammation | 0.78716615 |
| 85 | MP0000569_abnormal_digit_pigmentation | 0.78286181 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.77323846 |
| 87 | MP0004484_altered_response_of | 0.76546803 |
| 88 | MP0003828_pulmonary_edema | 0.76170906 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.72814179 |
| 90 | MP0001851_eye_inflammation | 0.71331412 |
| 91 | MP0004883_abnormal_blood_vessel | 0.70679871 |
| 92 | MP0000604_amyloidosis | 0.70677318 |
| 93 | MP0008874_decreased_physiological_sensi | 0.70502184 |
| 94 | MP0000920_abnormal_myelination | 0.70090994 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.69478904 |
| 96 | MP0003091_abnormal_cell_migration | 0.68806801 |
| 97 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68102006 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.67476638 |
| 99 | MP0002166_altered_tumor_susceptibility | 0.66847624 |
| 100 | MP0010352_gastrointestinal_tract_polyps | 0.66580549 |
| 101 | MP0000249_abnormal_blood_vessel | 0.66530049 |
| 102 | MP0005535_abnormal_body_temperature | 0.65908106 |
| 103 | MP0004043_abnormal_pH_regulation | 0.65308744 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.62397160 |
| 105 | MP0001663_abnormal_digestive_system | 0.62303063 |
| 106 | MP0000371_diluted_coat_color | 0.61719737 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.61053285 |
| 108 | MP0002090_abnormal_vision | 0.60410560 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.59808538 |
| 110 | MP0005646_abnormal_pituitary_gland | 0.59628721 |
| 111 | MP0003633_abnormal_nervous_system | 0.59049806 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.58307563 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.58199981 |
| 114 | MP0004019_abnormal_vitamin_homeostasis | 0.57816199 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.56957120 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.55434510 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.54825801 |
| 118 | MP0010307_abnormal_tumor_latency | 0.54267882 |
| 119 | MP0002254_reproductive_system_inflammat | 0.54207699 |
| 120 | MP0001501_abnormal_sleep_pattern | 0.52951018 |
| 121 | MP0003795_abnormal_bone_structure | 0.51060734 |
| 122 | MP0003045_fibrosis | 0.50573667 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.50384611 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.49609715 |
| 125 | MP0001881_abnormal_mammary_gland | 0.48679532 |
| 126 | MP0003763_abnormal_thymus_physiology | 0.47922498 |
| 127 | MP0005451_abnormal_body_composition | 0.46786392 |
| 128 | MP0008004_abnormal_stomach_pH | 0.44348394 |
| 129 | MP0005165_increased_susceptibility_to | 0.42435186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.53691468 |
| 2 | Recurrent abscess formation (HP:0002722) | 7.31564713 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.96797736 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.94398352 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 5.58550060 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 5.37394984 |
| 7 | Increased IgM level (HP:0003496) | 5.36534932 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.29283466 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.01538339 |
| 10 | Basal ganglia calcification (HP:0002135) | 4.57692114 |
| 11 | Stomatitis (HP:0010280) | 4.53598427 |
| 12 | Loss of speech (HP:0002371) | 4.48382494 |
| 13 | Vasculitis (HP:0002633) | 4.43001039 |
| 14 | Dysostosis multiplex (HP:0000943) | 4.32337909 |
| 15 | Gingivitis (HP:0000230) | 4.29409279 |
| 16 | Optic neuritis (HP:0100653) | 4.24113531 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 4.24113531 |
| 18 | Recurrent skin infections (HP:0001581) | 4.23498481 |
| 19 | Orchitis (HP:0100796) | 4.16193939 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 4.13870856 |
| 21 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.90199684 |
| 22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.90199684 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.90199684 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.86096120 |
| 25 | Myositis (HP:0100614) | 3.83906792 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.67013694 |
| 27 | Obstructive lung disease (HP:0006536) | 3.67013694 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 3.60028424 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 3.58315516 |
| 30 | Hypergammaglobulinemia (HP:0010702) | 3.57845166 |
| 31 | Vacuolated lymphocytes (HP:0001922) | 3.51467986 |
| 32 | Porencephaly (HP:0002132) | 3.49925260 |
| 33 | Neurofibrillary tangles (HP:0002185) | 3.47890504 |
| 34 | Mucopolysacchariduria (HP:0008155) | 3.44278160 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.44278160 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 3.44026330 |
| 37 | Recurrent viral infections (HP:0004429) | 3.30370340 |
| 38 | Periodontitis (HP:0000704) | 3.17104002 |
| 39 | Mutism (HP:0002300) | 3.13809299 |
| 40 | Thick nail (HP:0001805) | 3.08776642 |
| 41 | Poor head control (HP:0002421) | 3.07481999 |
| 42 | Hyperventilation (HP:0002883) | 3.04063743 |
| 43 | Apathy (HP:0000741) | 3.00818653 |
| 44 | Metaphyseal irregularity (HP:0003025) | 2.99569137 |
| 45 | Axonal loss (HP:0003447) | 2.98711382 |
| 46 | Diminished motivation (HP:0000745) | 2.98623769 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97040147 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97040147 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.94667010 |
| 50 | Recurrent pneumonia (HP:0006532) | 2.92725981 |
| 51 | Prostate neoplasm (HP:0100787) | 2.91991986 |
| 52 | Hematochezia (HP:0002573) | 2.91792649 |
| 53 | Cellulitis (HP:0100658) | 2.91298050 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.88501496 |
| 55 | Urticaria (HP:0001025) | 2.81934164 |
| 56 | Purpura (HP:0000979) | 2.76307570 |
| 57 | Petechiae (HP:0000967) | 2.74058077 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.73069238 |
| 59 | Cleft eyelid (HP:0000625) | 2.69669366 |
| 60 | Tetraparesis (HP:0002273) | 2.69583623 |
| 61 | Gingival bleeding (HP:0000225) | 2.61255753 |
| 62 | Increased serum ferritin (HP:0003281) | 2.60563100 |
| 63 | J-shaped sella turcica (HP:0002680) | 2.59981970 |
| 64 | Recurrent lower respiratory tract infections (HP:0002783) | 2.59581205 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.57649057 |
| 66 | Hemoptysis (HP:0002105) | 2.55388507 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.54908449 |
| 68 | Premature loss of primary teeth (HP:0006323) | 2.52651094 |
| 69 | Joint hemorrhage (HP:0005261) | 2.52514579 |
| 70 | Prolonged neonatal jaundice (HP:0006579) | 2.52180291 |
| 71 | Meningitis (HP:0001287) | 2.51387703 |
| 72 | Pustule (HP:0200039) | 2.50214680 |
| 73 | Abnormality of the pericardium (HP:0001697) | 2.49252885 |
| 74 | Chronic otitis media (HP:0000389) | 2.46398553 |
| 75 | Nuclear cataract (HP:0100018) | 2.44081675 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.43490784 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.43490784 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.43490784 |
| 79 | Leukocytosis (HP:0001974) | 2.41255447 |
| 80 | Joint swelling (HP:0001386) | 2.40495551 |
| 81 | Abnormality of T cell number (HP:0011839) | 2.39378391 |
| 82 | Increased CSF protein (HP:0002922) | 2.36529673 |
| 83 | Inappropriate behavior (HP:0000719) | 2.36264716 |
| 84 | Arterial thrombosis (HP:0004420) | 2.35272185 |
| 85 | Progressive neurologic deterioration (HP:0002344) | 2.31900778 |
| 86 | Osteomyelitis (HP:0002754) | 2.30150651 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.29356039 |
| 88 | Myocardial infarction (HP:0001658) | 2.29257741 |
| 89 | Skin nodule (HP:0200036) | 2.26159034 |
| 90 | Gangrene (HP:0100758) | 2.24842879 |
| 91 | Abnormality of the periventricular white matter (HP:0002518) | 2.24669513 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 2.23948761 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.22557512 |
| 94 | Hepatosplenomegaly (HP:0001433) | 2.21208476 |
| 95 | Nephritis (HP:0000123) | 2.19684715 |
| 96 | Parakeratosis (HP:0001036) | 2.19607721 |
| 97 | Anorexia (HP:0002039) | 2.19520961 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 2.18669918 |
| 99 | Hypophosphatemic rickets (HP:0004912) | 2.16615775 |
| 100 | Abnormality of the pleura (HP:0002103) | 2.13765219 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.11766342 |
| 102 | Keratoconjunctivitis (HP:0001096) | 2.10958061 |
| 103 | Spastic tetraparesis (HP:0001285) | 2.09601960 |
| 104 | Lower limb hyperreflexia (HP:0002395) | 2.09324577 |
| 105 | Arthralgia (HP:0002829) | 2.08644817 |
| 106 | Disinhibition (HP:0000734) | 2.07200052 |
| 107 | Plagiocephaly (HP:0001357) | 2.06605262 |
| 108 | Bone pain (HP:0002653) | 2.05383000 |
| 109 | Nausea (HP:0002018) | 2.05072063 |
| 110 | Abnormality of the basal ganglia (HP:0002134) | 2.04004424 |
| 111 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.03392347 |
| 112 | Cardiomegaly (HP:0001640) | 2.03193206 |
| 113 | Progressive visual loss (HP:0000529) | 2.01208329 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00546221 |
| 115 | Glomerulonephritis (HP:0000099) | 1.98486827 |
| 116 | Peritonitis (HP:0002586) | 1.97726402 |
| 117 | Irregular vertebral endplates (HP:0003301) | 1.95656123 |
| 118 | Vertebral compression fractures (HP:0002953) | 1.94570989 |
| 119 | Neuronal loss in central nervous system (HP:0002529) | 1.94296522 |
| 120 | Protuberant abdomen (HP:0001538) | 1.94009420 |
| 121 | Pigmentary retinal degeneration (HP:0001146) | 1.93865843 |
| 122 | Retinal atrophy (HP:0001105) | 1.92683722 |
| 123 | Adactyly (HP:0009776) | 1.92633092 |
| 124 | T lymphocytopenia (HP:0005403) | 1.91175638 |
| 125 | Micronodular cirrhosis (HP:0001413) | 1.91149441 |
| 126 | Curly hair (HP:0002212) | 1.90976225 |
| 127 | IgA deficiency (HP:0002720) | 1.89940237 |
| 128 | Sepsis (HP:0100806) | 1.87776614 |
| 129 | Eosinophilia (HP:0001880) | 1.85259262 |
| 130 | Xanthomatosis (HP:0000991) | 1.84812224 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84531981 |
| 132 | Osteolytic defects of the hand bones (HP:0009699) | 1.84531981 |
| 133 | Skin ulcer (HP:0200042) | 1.83850952 |
| 134 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.83366756 |
| 135 | Gastrointestinal stroma tumor (HP:0100723) | 1.82548626 |
| 136 | Agnosia (HP:0010524) | 1.82201996 |
| 137 | Global brain atrophy (HP:0002283) | 1.80753828 |
| 138 | Cerebral hemorrhage (HP:0001342) | 1.77932901 |
| 139 | Abnormality of the vertebral endplates (HP:0005106) | 1.77418014 |
| 140 | Fused cervical vertebrae (HP:0002949) | 1.76140230 |
| 141 | Recurrent bronchitis (HP:0002837) | 1.75937128 |
| 142 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.74912245 |
| 143 | Peripheral demyelination (HP:0011096) | 1.74803164 |
| 144 | Abnormality of the costochondral junction (HP:0000919) | 1.74720674 |
| 145 | Concave nail (HP:0001598) | 1.74400088 |
| 146 | Hypophosphatemia (HP:0002148) | 1.74388098 |
| 147 | Upper limb muscle weakness (HP:0003484) | 1.72481083 |
| 148 | Pathologic fracture (HP:0002756) | 1.72074184 |
| 149 | Ovoid vertebral bodies (HP:0003300) | 1.71874233 |
| 150 | Spondylolisthesis (HP:0003302) | 1.71504248 |
| 151 | Dementia (HP:0000726) | 1.70955683 |
| 152 | Tubulointerstitial fibrosis (HP:0005576) | 1.70693329 |
| 153 | Generalized aminoaciduria (HP:0002909) | 1.70541195 |
| 154 | Supranuclear gaze palsy (HP:0000605) | 1.69725018 |
| 155 | Deformed sella turcica (HP:0002681) | 1.68041967 |
| 156 | Enlarged epiphyses (HP:0010580) | 1.67451704 |
| 157 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.65160552 |
| 158 | Rickets (HP:0002748) | 1.65060614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.74047275 |
| 2 | MAP3K14 | 5.41090108 |
| 3 | RIPK4 | 4.51396495 |
| 4 | BLK | 3.86265397 |
| 5 | IRAK4 | 3.39599445 |
| 6 | TBK1 | 3.37363525 |
| 7 | TYK2 | 2.73254658 |
| 8 | JAK3 | 2.64859623 |
| 9 | IKBKE | 2.63922087 |
| 10 | IKBKB | 2.61396995 |
| 11 | IRAK3 | 2.58494714 |
| 12 | TAOK2 | 2.36753636 |
| 13 | MAP3K13 | 2.30252141 |
| 14 | MST1R | 2.16542701 |
| 15 | TXK | 2.15709417 |
| 16 | STK24 | 2.15505894 |
| 17 | DDR2 | 2.14171572 |
| 18 | PIM2 | 2.13356905 |
| 19 | BMPR2 | 2.12774685 |
| 20 | JAK1 | 1.82913347 |
| 21 | MST4 | 1.72727495 |
| 22 | CHUK | 1.63150889 |
| 23 | BMX | 1.61559254 |
| 24 | MAP3K11 | 1.54989200 |
| 25 | TGFBR2 | 1.51130537 |
| 26 | TAOK1 | 1.50455638 |
| 27 | ARAF | 1.41615741 |
| 28 | NEK9 | 1.40340468 |
| 29 | MAP3K3 | 1.40283072 |
| 30 | ABL2 | 1.39044188 |
| 31 | TIE1 | 1.38403135 |
| 32 | IRAK2 | 1.33823497 |
| 33 | NME2 | 1.30381317 |
| 34 | IRAK1 | 1.28518858 |
| 35 | ERN1 | 1.28186147 |
| 36 | SYK | 1.28095447 |
| 37 | ERBB3 | 1.26235486 |
| 38 | EIF2AK2 | 1.25998002 |
| 39 | GRK1 | 1.25021250 |
| 40 | CSK | 1.24783578 |
| 41 | LIMK1 | 1.17664022 |
| 42 | MAP4K1 | 1.14566259 |
| 43 | STK38L | 1.11681166 |
| 44 | STK4 | 1.08233778 |
| 45 | MARK3 | 1.06955833 |
| 46 | CDC42BPA | 1.05529251 |
| 47 | KIT | 1.05346629 |
| 48 | MAP3K9 | 1.00349160 |
| 49 | TESK2 | 0.99872859 |
| 50 | EIF2AK3 | 0.98851642 |
| 51 | SIK3 | 0.98845657 |
| 52 | HCK | 0.97401668 |
| 53 | LYN | 0.97123376 |
| 54 | ZAP70 | 0.96207175 |
| 55 | PIM1 | 0.95748562 |
| 56 | TRPM7 | 0.95408010 |
| 57 | YES1 | 0.92224078 |
| 58 | MAP2K6 | 0.90625810 |
| 59 | MAP3K12 | 0.87855488 |
| 60 | JAK2 | 0.86032778 |
| 61 | MAP2K3 | 0.85233620 |
| 62 | LCK | 0.83750143 |
| 63 | MAP3K5 | 0.83488291 |
| 64 | MATK | 0.82312258 |
| 65 | FGR | 0.80851793 |
| 66 | ERBB4 | 0.78085153 |
| 67 | BMPR1B | 0.76201952 |
| 68 | PRKCD | 0.73179641 |
| 69 | CAMKK2 | 0.71368508 |
| 70 | BTK | 0.70843439 |
| 71 | PRKCQ | 0.69973880 |
| 72 | BCR | 0.69810249 |
| 73 | FLT3 | 0.67565082 |
| 74 | RPS6KA4 | 0.64795434 |
| 75 | CAMK1D | 0.62379756 |
| 76 | EPHB1 | 0.60963772 |
| 77 | PAK4 | 0.57508819 |
| 78 | ABL1 | 0.57105750 |
| 79 | PDGFRB | 0.56036073 |
| 80 | EPHA3 | 0.55782401 |
| 81 | EPHA2 | 0.53887529 |
| 82 | FGFR3 | 0.53613386 |
| 83 | MAPK15 | 0.53283462 |
| 84 | RPS6KA2 | 0.52845261 |
| 85 | GRK7 | 0.51537151 |
| 86 | ADRBK2 | 0.51048805 |
| 87 | RPS6KC1 | 0.50375855 |
| 88 | RPS6KL1 | 0.50375855 |
| 89 | TESK1 | 0.50222485 |
| 90 | MAPK4 | 0.49540239 |
| 91 | GRK5 | 0.49518020 |
| 92 | PLK2 | 0.49437612 |
| 93 | DAPK3 | 0.49176532 |
| 94 | FRK | 0.48747941 |
| 95 | PRKG2 | 0.48175591 |
| 96 | PDK2 | 0.47785083 |
| 97 | FGFR4 | 0.47504550 |
| 98 | EGFR | 0.46305158 |
| 99 | GRK6 | 0.43558433 |
| 100 | MAP3K10 | 0.43465973 |
| 101 | GSK3A | 0.42911716 |
| 102 | TEC | 0.41280922 |
| 103 | MUSK | 0.41206716 |
| 104 | MOS | 0.37742284 |
| 105 | PIK3CG | 0.36971125 |
| 106 | PDGFRA | 0.36517428 |
| 107 | MET | 0.36105466 |
| 108 | PRKCE | 0.36091767 |
| 109 | PKN1 | 0.35494266 |
| 110 | PTK2B | 0.34797212 |
| 111 | MAPKAPK5 | 0.34033643 |
| 112 | CAMK4 | 0.33655138 |
| 113 | CLK1 | 0.32751808 |
| 114 | CSF1R | 0.31165592 |
| 115 | TAOK3 | 0.30801153 |
| 116 | FER | 0.29187680 |
| 117 | STK3 | 0.29133864 |
| 118 | DAPK2 | 0.28817523 |
| 119 | FES | 0.28338855 |
| 120 | CAMK1G | 0.25455341 |
| 121 | ADRBK1 | 0.25398085 |
| 122 | MELK | 0.25342309 |
| 123 | PRPF4B | 0.24895273 |
| 124 | BRAF | 0.21608943 |
| 125 | IGF1R | 0.21351715 |
| 126 | RIPK1 | 0.21292168 |
| 127 | NLK | 0.20726877 |
| 128 | INSR | 0.19982082 |
| 129 | MAP3K1 | 0.19121443 |
| 130 | FYN | 0.18686992 |
| 131 | RPS6KA1 | 0.18653727 |
| 132 | TTN | 0.18134845 |
| 133 | MAPKAPK2 | 0.16718224 |
| 134 | SIK2 | 0.15931499 |
| 135 | RPS6KA5 | 0.15714476 |
| 136 | KSR2 | 0.15345690 |
| 137 | EPHB2 | 0.14351671 |
| 138 | PDPK1 | 0.13313558 |
| 139 | PDK1 | 0.11587365 |
| 140 | STK10 | 0.11045402 |
| 141 | RPS6KA6 | 0.10844231 |
| 142 | ACVR1B | 0.10474123 |
| 143 | SRC | 0.09849538 |
| 144 | LRRK2 | 0.08803084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.75731705 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.95193389 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.39458827 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.22607798 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.20164321 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.96984473 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.79588500 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.76349595 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.72326857 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.54995688 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.49827594 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.38757957 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.35970827 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.35896008 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.25544120 |
| 16 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.18969003 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14850229 |
| 18 | Measles_Homo sapiens_hsa05162 | 2.14506096 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.12555173 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 2.09531443 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.99235681 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.98153226 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.96631397 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85643704 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.82908127 |
| 26 | Bladder cancer_Homo sapiens_hsa05219 | 1.67712321 |
| 27 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.63367138 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53163743 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.47299171 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39863668 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34896996 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34696228 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29386652 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.24543600 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17014538 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15694427 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.14488384 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.07707290 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04375551 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01933788 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 0.98590361 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97216092 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 0.96214253 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95966766 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93408963 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91756881 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 0.89673145 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88825822 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86285809 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.85682236 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.85663055 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85539894 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85346465 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84667873 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79082539 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.78549511 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75150257 |
| 58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71643024 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66437602 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61612851 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54889637 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54240090 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53880810 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50513926 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50000910 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49984135 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49096047 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49002994 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48290145 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47830629 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46836882 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46674191 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43773106 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41376032 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41164004 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40273438 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33903778 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.32653081 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.32483647 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.32470649 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32182323 |
| 82 | Proteasome_Homo sapiens_hsa03050 | 0.32054067 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31418299 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30687517 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29997574 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.29024499 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.28289579 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27523360 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27161015 |
| 90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26767291 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25499342 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24319077 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23957565 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23839145 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21236035 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20701320 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20610760 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19160229 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17563687 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16610754 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.16292185 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.15660976 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14634782 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.14385091 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.13436042 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.11886315 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.11122226 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.09402500 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.09322785 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.08199848 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.07939519 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.07208849 |
| 113 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.06558973 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.05748382 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.05004667 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.04051415 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.03108058 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.02754819 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.01259818 |
| 120 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.01131007 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0458453 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0415360 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0054434 |

